ARTICLE | Company News
AlphaCore, AstraZeneca deal
April 8, 2013 7:00 AM UTC
AstraZeneca's MedImmune LLC biologics unit acquired cardiovascular company AlphaCore. The companies declined to provide details. AlphaCore is developing ACP-501, a recombinant human lecithin-choles...